2020
DOI: 10.1007/s10529-020-02846-9
|View full text |Cite
|
Sign up to set email alerts
|

CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
37
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 64 publications
(37 citation statements)
references
References 29 publications
0
37
0
Order By: Relevance
“…CircRNAs are also involved in tumor progression and chemoresistance in diverse cancers [ 12 ]. For instance, circRNA AKT3 impeded cisplatin chemosensitivity via regulating glycolysis balance through modulation of the miR-516b-5p/STAT3 axis in lung cancer cells [ 13 ]. Circular RNA hsa_circ_0000735 (hsa_circ_0000735) is derived from the P2RX1 gene (exons 2–8).…”
Section: Introductionmentioning
confidence: 99%
“…CircRNAs are also involved in tumor progression and chemoresistance in diverse cancers [ 12 ]. For instance, circRNA AKT3 impeded cisplatin chemosensitivity via regulating glycolysis balance through modulation of the miR-516b-5p/STAT3 axis in lung cancer cells [ 13 ]. Circular RNA hsa_circ_0000735 (hsa_circ_0000735) is derived from the P2RX1 gene (exons 2–8).…”
Section: Introductionmentioning
confidence: 99%
“…In ovarian cancer, Cdr1as was downregulated in cisplatin-resistant tissue and directly interacted with miR-1270 to increase SCAI [172]. CircAKT3 has also been associated with cisplatin resistance in lung cancer via miR-516b-5p/STAT3 [173] and in gastric cancer via miR-198/PIK3R1 [174]. CircPGC also increases cisplatin resistance via the STAT3 pathway in NSCLC by sponging miR-296-5p [175].…”
Section: Chemotherapymentioning
confidence: 99%
“…Two different works have recently been published describing circRNAs that regulate the expression of STAT3. Dong et al [48] reported that upregulation of hsa_circ_0076305 confers DDP-resistance to NSCLC cells via sponging miR-296-5p, positively modulating STAT3. Xu et al [49] introduced the role of circAKT3 inhibiting cisplatin sensitivity by regulating mir-516b-5p/STAT3 axis.…”
Section: Circrnas As Biomarkers Of Treatment Resistance In Nsclcmentioning
confidence: 99%